Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 19

    1.

    Possible short-term changes of aqueous inflammatory cytokines after intravitreal bevacizumab for diabetic macular edema.

    Lee WJ, Cho HY.

    Am J Ophthalmol. 2012 Feb;153(2):387-8; author reply 388. No abstract available.

    PMID:
    22264958
    [PubMed - indexed for MEDLINE]
    2.

    Correlation between plasma pentosidine concentrations and retinal hemodynamics in patients with type 2 diabetes.

    Sato E, Nagaoka T, Yokota H, Takahashi A, Yoshida A.

    Am J Ophthalmol. 2012 May;153(5):903-909.e1. Epub 2012 Jan 21.

    PMID:
    22265156
    [PubMed - in process]
    3.

    Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.

    Matsumoto M, Suzuma K, Maki T, Kinoshita H, Tsuiki E, Fujikawa A, Kitaoka T.

    Am J Ophthalmol. 2012 May;153(5):896-902.e1. Epub 2012 Jan 20.

    PMID:
    22265145
    [PubMed - in process]
    4.

    Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema.

    Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N, Muraoka Y, Ellabban AA, Yoshimura N.

    Am J Ophthalmol. 2012 Apr;153(4):710-7, 717.e1. Epub 2011 Dec 3.

    PMID:
    22137207
    [PubMed - indexed for MEDLINE]
    5.

    Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing diabetic macular edema.

    Medina FJ, Callén CI, Rebolleda G, Muñoz-Negrete FJ, Callén MJ, del Valle FG.

    Am J Ophthalmol. 2012 Mar;153(3):536-543.e1. Epub 2011 Oct 11.

    PMID:
    21996307
    [PubMed - indexed for MEDLINE]
    6.

    Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.

    Ma Y, Zhang Y, Zhao T, Jiang YR.

    Am J Ophthalmol. 2012 Feb;153(2):307-313.e2. Epub 2011 Oct 7.

    PMID:
    21982107
    [PubMed - indexed for MEDLINE]
    7.

    Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser.

    Chappelow AV, Tan K, Waheed NK, Kaiser PK.

    Am J Ophthalmol. 2012 Jan;153(1):137-42.e2. Epub 2011 Sep 19.

    PMID:
    21937017
    [PubMed - indexed for MEDLINE]
    8.

    Revisiting Diabetes 2000: challenges in establishing nationwide diabetic retinopathy prevention programs.

    Hazin R, Colyer M, Lum F, Barazi MK.

    Am J Ophthalmol. 2011 Nov;152(5):723-9. Epub 2011 Sep 13. Review.

    PMID:
    21917235
    [PubMed - indexed for MEDLINE]
    9.

    Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes.

    Sasongko MB, Wong TY, Donaghue KC, Cheung N, Jenkins AJ, Benitez-Aguirre P, Wang JJ.

    Am J Ophthalmol. 2012 Jan;153(1):176-83.e1. Epub 2011 Sep 9.

    PMID:
    21907319
    [PubMed - indexed for MEDLINE]
    10.

    Emerging evidence concerning systemic safety of anti-VEGF agents--should ophthalmologists be concerned?

    Lim LS, Cheung CM, Mitchell P, Wong TY.

    Am J Ophthalmol. 2011 Sep;152(3):329-31. No abstract available.

    PMID:
    21855670
    [PubMed - indexed for MEDLINE]
    12.

    Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.

    Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY, Nam DH.

    Am J Ophthalmol. 2011 Oct;152(4):686-94. Epub 2011 Jul 22.

    PMID:
    21782151
    [PubMed - indexed for MEDLINE]
    13.

    Does laser still have a role in the management of retinal vascular and neovascular diseases?

    Shah AM, Bressler NM, Jampol LM.

    Am J Ophthalmol. 2011 Sep;152(3):332-339.e1. Epub 2011 Jul 13.

    PMID:
    21742309
    [PubMed - indexed for MEDLINE]
    14.

    Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.

    Lange CA, Stavrakas P, Luhmann UF, de Silva DJ, Ali RR, Gregor ZJ, Bainbridge JW.

    Am J Ophthalmol. 2011 Sep;152(3):406-412.e3. Epub 2011 Jul 2.

    PMID:
    21723532
    [PubMed - indexed for MEDLINE]
    15.

    Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy.

    Ma Y, Tao Y, Lu Q, Jiang YR.

    Am J Ophthalmol. 2011 Oct;152(4):678-685.e2. Epub 2011 Jun 25.

    PMID:
    21704966
    [PubMed - indexed for MEDLINE]
    16.

    The relationship between macular sensitivity and retinal thickness in eyes with diabetic macular edema.

    Hatef E, Colantuoni E, Wang J, Ibrahim M, Shulman M, Adhi F, Sepah YJ, Channa R, Khwaja A, Nguyen QD, Do DV.

    Am J Ophthalmol. 2011 Sep;152(3):400-405.e2. Epub 2011 Jun 21.

    PMID:
    21696702
    [PubMed - indexed for MEDLINE]
    17.

    Diabetic retinopathy in the developing world: how to approach identifying and treating underserved populations.

    Friedman DS, Ali F, Kourgialis N.

    Am J Ophthalmol. 2011 Feb;151(2):192-4.e1. No abstract available.

    PMID:
    21251492
    [PubMed - indexed for MEDLINE]
    18.

    Relationship between sleep-disordered breathing and iris and/or angle neovascularization in proliferative diabetic retinopathy cases.

    Shiba T, Takahashi M, Hori Y, Saishin Y, Sato Y, Maeno T.

    Am J Ophthalmol. 2011 Apr;151(4):604-9. Epub 2011 Jan 22.

    PMID:
    21257149
    [PubMed - indexed for MEDLINE]
    19.

    Ophthalmodynamometric pressure in eyes with proliferative diabetic retinopathy measured during pars plana vitrectomy.

    Sugiura Y, Okamoto F, Okamoto Y, Hasegawa Y, Hiraoka T, Oshika T.

    Am J Ophthalmol. 2011 Apr;151(4):624-629.e1. Epub 2011 Jan 13.

    PMID:
    21236404
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk